PNTG · XBRL financial data

The Pennant Group financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (PNTG's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	390,953	439,694	473,241	544,891	695,240	947,705
Selling, general and administrative	—	36,259	33,981	36,667	50,209	71,077
Operating income (loss)	18,917	4,695	12,739	25,169	38,116	51,886
Interest expense	1,239	1,941	3,816	5,924	6,956	6,678
Other income (expense)	225	(24)	(31)	339	207	422
Income tax expense (benefit)	2,350	582	1,649	5,674	7,028	11,866
Net income (loss)	15,744	2,696	6,643	13,379	22,559	29,578
Earnings per share, basic USD per share	0.56	0.09	0.23	0.45	0.72	0.86
Earnings per share, diluted USD per share	0.52	0.09	0.22	0.44	0.70	0.84
Weighted average shares, basic thousands of shares	28,029	28,406	29,064	29,863	31,191	34,563
Weighted average shares, diluted thousands of shares	30,228	30,642	30,159	30,193	32,000	35,316

Fiscal years (PNTG's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	43	5,190	2,079	6,059	24,246	17,024
Accounts receivable	47,221	53,940	53,420	61,116	81,302	123,109
Prepaid and other current assets	12,335	16,711	18,323	12,902	17,308	27,273
Total current assets	59,599	75,841	73,822	80,077	122,856	167,406
Property and equipment, net	17,884	16,788	26,621	28,598	43,296	60,984
Right-of-use asset	308,650	300,997	260,868	262,923	270,586	275,947
Goodwill	66,444	74,265	79,497	91,014	129,124	237,246
Total assets	506,976	530,297	512,119	539,691	679,521	968,179
Accounts payable	9,761	10,553	13,647	10,841	18,737	25,171
Current portion of long-term debt	—	—	—	—	0	5,000
Total current liabilities	89,015	71,635	70,247	71,549	101,700	147,264
Lease liability, non-current	296,615	287,753	247,042	248,596	253,420	254,311
Total liabilities	405,804	416,053	386,462	394,176	367,556	593,927
Retained earnings	11,945	14,641	21,284	34,663	57,222	86,800
Total liabilities and equity	506,976	530,297	512,119	539,691	679,521	968,179
Common shares outstanding (cover page) thousands of shares	28,262	28,530	29,706	30,013	34,430	34,663

Fiscal years (PNTG's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	15,744	2,696	6,643	13,379	22,559	29,578
Stock-based compensation	8,335	10,040	3,086	5,369	7,781	8,940
Depreciation and amortization	4,675	4,784	4,900	5,130	6,119	8,538
Net cash from operating activities	50,204	(18,223)	9,044	33,090	39,298	48,294
Purchases of property and equipment	7,253	6,303	14,170	8,105	8,992	12,039
Net cash from investing activities	(41,616)	(20,120)	(24,239)	(30,222)	(70,684)	(227,971)
Share repurchases	65	0	0	—	—	—
Dividends paid	0	0	—	—	—	—
Net cash from financing activities	(8,947)	43,490	12,084	1,112	49,573	172,455
Net change in cash	(359)	5,147	(3,111)	3,980	18,187	(7,222)

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Pennant Group	15,273	297,984	21,830*	34.9M	—	Q2 FY26 10-QJun 30, 2026
Omada Health	221,712	87,835	4,007*	61.2M	—	Q2 FY26 10-QJun 30, 2026
LifeStance Health Group	225,943	435,354	99,912*	382.1M	—	Q2 FY26 10-QJun 30, 2026
U S Physical Therapy	24,887	214,059	34,370*	14.9M	—	Q2 FY26 10-QJun 30, 2026
GeneDx Holdings	60,317	114,440	(28,981)*	29.8M	4.6 quarters	Q2 FY26 10-QJun 30, 2026
Privia Health Group	412,200	not reported	1,100*	127.7M	—	Q2 FY26 10-QJun 30, 2026
Talkspace	39,159	61,672	11,385*	165.8M	—	Q2 FY26 10-QJun 30, 2026
Strata Critical Medical	35,136	74,081	9,458*	89.3M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.